Lung Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. Our lung cancer clinical trials give patients access to new and innovative treatments.

Current clinical trials often include studies for non small cell lung cancer and innovative immunotherapy approaches.

Learn more about participating in a clinical trial at Norton Healthcare.

Active lung cancer clinical trials at Norton Cancer Institute include:

Limited Stage Small Cell Lung Cancer (LS-SCLC)

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study Of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Lung Cancer/ Breast Cancer

A Phase 1 Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses and treatment intensification of a vaccine-based immunotherapy Regimen-2 (VBIR-2) (PF-06936308) for advanced non-small cell lung cancer and metastatic triple-negative breast cancer

Non-Small Cell Lung Cancer (NSCLC)

LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields)in combination with PD-1 inhibitors or docetaxel, for second line treatment of non-small cell lung cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC)

A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects with PD-L1+ Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 versus Pembrolizumab as a First line Treatment in Patients with PD-L1 Expressing Advanced Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

A Phase 2, Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST)

Pulmonary Nodules

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Small Cell Carcinoma

REPLATINUM: A Phase 3, Controlled, Open-label, Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer

Small Cell Lung Cancer (SCLC)

A Phase 1 Dose Escalation and Expanded Cohort Study of PF-06821497 in the treatment of adult patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC), and Follicular Lymphoma (FL)

Solid Tumors

Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Nurses arrange Louisville Cardinals men’s basketball visit for cancer patient

Jeremiah Howe’s last wish was to go to Louisville Cardinals basketball game. With advanced cancer, he needed to remain in the hospital for care. But the nursing team at Norton Hospital started working their contacts […]

Read Full Story

Kentucky has country’s highest rate of lung cancer diagnoses; lung cancer screenings urged

Nearly one in every thousand Kentuckians will be newly diagnosed with lung cancer this year — the worst rate in the nation — and most of those cases will be found after the cancer has […]

Read Full Story

Study shows vaping nicotine could cause cancer

New research shows vaping’s dangers may extend beyond the recent wave of deaths from pulmonary disease, as vaping also may increase cancer risk. The first study linking vaping to cancer found nearly 25% of mice […]

Read Full Story

How to quit smoking: Make a plan

You’ve made the decision to quit smoking, now what? Don’t try to do it right away. You need to make a plan and let those closest to you know you have decided to quit. Accept […]

Read Full Story

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story
Related Stories

Nurses arrange Louisville Cardinals men’s basketball visit for cancer patient

Jeremiah Howe’s last wish was to go to Louisville Cardinals basketball game. With advanced cancer, he needed to remain in the hospital for care. But the nursing team at Norton Hospital started working their contacts […]

Read Full Story

Kentucky has country’s highest rate of lung cancer diagnoses; lung cancer screenings urged

Nearly one in every thousand Kentuckians will be newly diagnosed with lung cancer this year — the worst rate in the nation — and most of those cases will be found after the cancer has […]

Read Full Story

Study shows vaping nicotine could cause cancer

New research shows vaping’s dangers may extend beyond the recent wave of deaths from pulmonary disease, as vaping also may increase cancer risk. The first study linking vaping to cancer found nearly 25% of mice […]

Read Full Story

How to quit smoking: Make a plan

You’ve made the decision to quit smoking, now what? Don’t try to do it right away. You need to make a plan and let those closest to you know you have decided to quit. Accept […]

Read Full Story

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.